Recruiting

PCSK9 Inhibition

Sponsor:

Massachusetts General Hospital

Code:

NCT05720156

Conditions

Atherosclerotic Cardiovascular Disease

Cardiovascular Diseases

Atherosclerosis

Arterial Inflammation

Vascular Diseases

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

99mTc-tilmanocept SPECT/CT scanning

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2024-05-10.